A better portfolio, but no public stock
- Hillenbrand is now private after Lone Star completed its cash deal in February 2026.
- The operating story is a cleaner APS and MTS portfolio after MIME and TerraSource exits.
- APS produced $507 million of Q3 2025 revenue, but large customer projects were delayed.
- Food, Health and Nutrition is meant to make the company less cyclical over time.
- Debt was still heavy, with pro forma net leverage near 3.7x after the TerraSource sale.
Cleaner business, closed public chapter
Hillenbrand’s public equity story ended in February 2026, when Lone Star completed its all-cash acquisition. Public shareholders were set to receive $32.00 per share, and HI common stock stopped trading on the NYSE. That means a retail investor can study the business, but cannot buy the old public common stock.
Before the deal closed, the bull case was about focus. Hillenbrand had sold MIME and TerraSource, leaving two core businesses: Advanced Process Solutions, or APS, and Molding Technology Solutions, or MTS. Management said these remaining businesses had higher margins, better growth potential, and stronger returns on capital than the old mix.
The key asset is technical know-how, especially around Coperion. Hillenbrand sells complex processing systems, then supports them with parts and service. The company also hit $30 million of run-rate cost synergies from the Linxis and FPM acquisitions much faster than planned, which gives the bull case some real proof.
The bear case is timing and debt. APS depends on large capital projects, and customers were delaying orders because of macro and tariff uncertainty. Management said these were delays, not cancellations, but if delays last too long, revenue, margins, cash flow, and debt paydown all come under pressure.
Big machines, sticky service
Hillenbrand makes highly engineered equipment and systems used in industrial processing. Customers buy machines and full systems for plastics, food, health, nutrition, and related markets. These sales can be large and slow, because customers often approve them as capital projects.
The company also earns money after the first sale. Its installed base needs parts, upgrades, service, and support. That aftermarket work is important because it tends to be steadier than a new plant or production line order.
APS is the bigger, longer-cycle business. It can win large projects, but a few delayed orders can move a whole quarter. MTS is shorter-cycle and more tied to hot runner systems and mold components, but it faces pricing pressure in competitive plastics markets.
The model breaks when customers stop committing cash. In Q3 2025, cash from operations was a use of about $2 million, partly because lower order volume reduced customer advances. Those advances matter because customers often pay part of a project before Hillenbrand builds and ships it.
What Hillenbrand sells
Coperion compounding and extrusion systems
These systems process materials such as plastics and performance materials. Coperion is central to Hillenbrand’s technical edge and global reach.
Feeding and weighing equipment
These products help control how materials move through a production process. Accuracy matters, so customers value engineering support and service.
Food, Health and Nutrition systems
This includes the Linxis and FPM acquisitions. Management says this market is less cyclical and now represents more than 25% of global revenue.
Hot runner systems
Hot runners are used in plastic molding. This is part of MTS and tends to move faster than the big APS project business.
Mold components and controllers
These products support plastics molding customers. Management pointed to controller orders as a possible early sign of future hot runner demand.
Aftermarket parts and service
Once Hillenbrand equipment is installed, customers need parts and service. This creates repeat revenue and makes customer relationships stickier.
APS does most of the work
Segment mix uses fiscal Q3 2025 revenue from management’s earnings call after the MIME divestiture: APS at $507 million and MTS pro forma at $92 million. APS depends more on large projects, so the mix can move by quarter.
What can still go wrong
No public common stock
High impact · High oddsHillenbrand is no longer a normal public stock after the Lone Star acquisition closed in February 2026. The old HI common shares stopped trading on the NYSE. For a retail investor, the main issue is access, not only business quality.
APS order delays last longer
High impact · Medium oddsAPS sells large systems, so customers can delay orders when trade policy or the economy looks unclear. In Q3 2025, APS revenue fell 11% year over year and backlog fell 10%. Management saw post-quarter order wins, but the recovery still needed proof.
Debt limits flexibility
High impact · Medium oddsThe balance sheet was leveraged before the take-private deal. Management cited net debt to pro forma adjusted EBITDA of 3.9x at quarter-end, with an implied 3.7x after TerraSource proceeds. If orders stay weak, paying debt down gets harder.
Commercial synergies do not show up
Medium impact · Medium oddsHillenbrand already hit the $30 million cost synergy target from Linxis and FPM. The next step is harder: selling more food and nutrition systems through Coperion’s global footprint. Cost savings are visible now, but sales synergies still need time.
Tariffs squeeze timing and margins
Medium impact · High oddsTariff uncertainty was a direct reason customers delayed projects in Q3 2025. Hillenbrand used surcharges and contract changes to reduce the hit. Those tools may not fully protect margins if trade rules change again or customers resist price increases.
In one breath
Is Hillenbrand still publicly traded?
No. Lone Star completed its acquisition of Hillenbrand in February 2026, and HI common stock stopped trading on the NYSE. Public shareholders were set to receive $32.00 per share in cash.
What does Hillenbrand actually make?
Hillenbrand makes industrial processing and molding equipment. Its systems help customers process plastics, food, health, nutrition, and performance materials.
Why did Hillenbrand’s orders slow in 2025?
Customers delayed large capital projects because of macro and tariff uncertainty. Management said it viewed the weakness as project delays, not cancellations, but that still hurt APS revenue and cash flow.
What was the main upside case before the sale?
The upside case was that Hillenbrand had become a cleaner, higher-margin company after divestitures. If APS orders recovered and FHN cross-selling worked, margins and cash flow could improve.